Geode Capital Management
SHPH icon

Geode Capital Management’s Shuttle Pharmaceuticals SHPH Stock Holding History

Geode Capital Management’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.4K Buy
4,622
+3,178
+220% +$43.1K ﹤0.01% 4399
2025
Q4 		$26K Buy
+1,444
New +$36.9K ﹤0.01% 4350
2025
Q2 		– Sell
-136
Closed -$13.2K – 4510
2025
Q1 		$13.2K Buy
136
+93
+216% +$15.1K ﹤0.01% 4411
2024
Q4 		$9.06K Buy
+43
New +$11.2K ﹤0.01% 4447
2024
Q3 		– Sell
-15
Closed -$12.3K – 4575
2024
Q2 		$12.3K Sell
15
-3
-17% -$2.55K ﹤0.01% 4522
2024
Q1 		$15K Hold
18
– – ﹤0.01% 4514
2023
Q4 		$16.5K Hold
18
– – ﹤0.01% 4546
2023
Q3 		$22.5K Buy
+18
New +$29.7K ﹤0.01% 4598

Other funds holding SHPH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's SHPH Position: Q1 2026 in Review

Geode Capital Management increased its Shuttle Pharmaceuticals (SHPH) stake by 220% in Q1 2026, buying an estimated $43.1K and bringing the position to 4,622 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4399.

Geode Capital Management first reported a position in SHPH in Q3 2023 and has held it in 8 quarters since. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

  • Geode Capital Management held 4,622 shares of Shuttle Pharmaceuticals worth $31.4K as of Q1 2026.
  • Geode Capital Management bought 3,178 Shuttle Pharmaceuticals shares in Q1 2026, an estimated $43.1K.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4399 holding.
  • Geode Capital Management first reported a position in Shuttle Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • 8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.